vimarsana.com

Latest Breaking News On - University witten herdecke - Page 1 : vimarsana.com

Axsome Therapeutics Highlights Data on Solriamfetol Demonstrating Improvement in Cognitive Function in Patients with Obstructive Sleep Apnea or Narcolepsy at SLEEP 2024

Axsome Therapeutics, Inc. , a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, today announced five presentations, including two featured oral plenary presentations, on.

Axsome to Present Findings on Solriamfetol s Cognitive Benefits

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.